Benznidazole Tx Explored in Chagas' Cardiomyopathy

This article originally appeared here.
Share this content:
Benznidazole Tx Explored in Chagas' Cardiomyopathy
Benznidazole Tx Explored in Chagas' Cardiomyopathy

TUESDAY, Sept. 1, 2015 (HealthDay News) -- For patients with established Chagas' cardiomyopathy, benznidazole reduces serum parasite detection, according to a study published online Sept. 1 in the New England Journal of Medicine to coincide with the annual European Society of Cardiology Congress, held from Aug. 29 to Sept. 2 in London.

Carlos A. Morillo, M.D., from Hamilton Health Sciences and McMaster University in Canada, and colleagues conducted a prospective randomized trial involving 2,854 patients with Chagas' cardiomyopathy who received benznidazole or placebo for up to 80 days. Patients were followed for a mean of 5.4 years.

The researchers found that the primary outcome (first event of a composite of death, resuscitated cardiac arrest, sustained ventricular tachycardia, insertion of a pacemaker or implantable cardioverter-defibrillator, cardiac transplantation, new heart failure, stroke, or other thromboembolic event) occurred in 27.5 and 29.1 percent of the benznidazole and placebo groups, respectively (P = 0.31). In polymerase chain reaction (PCR), 60.5 percent of patients had positive results for Trypanosoma cruzi at baseline. At the end of treatment, the rates of conversion from negative PCR results were 66.2 and 33.5 percent in the benznidazole and placebo groups, respectively; at two years the rates were 55.4 and 35.3 percent, respectively, and at five or more years, 46.7 and 33.1 percent, respectively (P < 0.001 for all comparisons).

"Benznidazole treatment significantly reduced the detection of circulating parasites but did not reduce cardiac clinical progression," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »